Close
ACHEMA MIDDLE EAST 2026

New Pharma Legislation May Affect Europe R&D Significantly

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a...

Vetter In Rankweil Gets Permanent Manufacturer Authorization

Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in...

Global Healthcare Access Improved By Indian Pharma Cos.

As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes...

Improving Approach of UK Through Future Clinical Trials Bill

The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving...

CDMO-Biotech Ties Help Cut Business Risk In Drug Development

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...

Veramed expands its global footprint by acquiring Clinical Trial Data Services

Specialist Biometrics CRO, Veramed, announced the acquisition of Boston-based data management, biostatistics and medical writing company, CTDS. The deal will enhance Veramed’s global presence...

New MHRA Regulation Revamps Lowest-Risk UK Clinical Trials

The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...